Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

Neuron | Feb 28, 1997

http://www.ncbi.nlm.nih.gov/pubmed/9052802

High levels of familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 mutants G93A and G37R were previously shown to mediate disease in mice through an acquired toxic property. We report here that even low levels of another mutant, G85R, cause motor neuron disease characterized by an extremely rapid clinical progression, without changes in SOD1 activity. Initial indicators of disease are astrocytic inclusions that stain intensely with SOD1 antibodies and ubiquitin and SOD1-containing aggregates in motor neurons, features common with some cases of SOD1 mutant-mediated ALS. Astrocytic inclusions escalate markedly as disease progresses, concomitant with a decrease in the glial glutamate transporter (GLT-1). Thus, the G85R SOD1 mutant mediates direct damage to astrocytes, which may promote the nearly synchronous degeneration of motor neurons.

Pubmed ID: 9052802 RIS Download

Mesh terms: ATP-Binding Cassette Transporters | Amino Acid Transport System X-AG | Amyotrophic Lateral Sclerosis | Animals | Astrocytes | Axons | Disease Models, Animal | Genes, Dominant | Humans | Mice | Mice, Transgenic | Microscopy, Electron | Nerve Degeneration | Neurons | Point Mutation | Spinal Cord | Superoxide Dismutase | Ubiquitins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIA NIH HHS, Id: AG 05146
  • Agency: NINDS NIH HHS, Id: NS 10580
  • Agency: NINDS NIH HHS, Id: NS 27036

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.